Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psychedelic Psychiatry’s Brave New World
David Nutt, David Erritzøe, Robin Carhart‐Harris
Cell (2020) Vol. 181, Iss. 1, pp. 24-28
Open Access | Times Cited: 257

Showing 26-50 of 257 citing articles:

The acute effects of classic psychedelics on memory in humans
C. J. Healy
Psychopharmacology (2021) Vol. 238, Iss. 3, pp. 639-653
Closed Access | Times Cited: 73
Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?
Rita Kočárová, Jiřı́ Horáček, Robin Carhart‐Harris
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 68
Psychedelics therapeutics: What we know, what we think, and what we need to research
David Nutt, Meg J. Spriggs, David Erritzøe
Neuropharmacology (2022) Vol. 223, pp. 109257-109257
Open Access | Times Cited: 64
Pattern breaking: a complex systems approach to psychedelic medicine
Inês Hipólito, Jonas Mago, Fernando Rosas, et al.
Neuroscience of Consciousness (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 39
How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change
Richard J. Zeifman, Anne Catherine Wagner, Candice M. Monson, et al.
Journal of Affective Disorders (2023) Vol. 334, pp. 100-112
Open Access | Times Cited: 31
5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice
Sarah J. Jefferson, Ian Gregg, Mark Dibbs, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 9, pp. 1257-1266
Open Access | Times Cited: 30
Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants
Wenwen Duan, Dongmei Cao, Sheng Wang, et al.
Chemical Reviews (2023) Vol. 124, Iss. 1, pp. 124-163
Closed Access | Times Cited: 30
Are psychedelics the answer to chronic pain: A review of current literature
Nina Kooijman, Tim Willegers, Anke Reuser, et al.
Pain Practice (2023) Vol. 23, Iss. 4, pp. 447-458
Open Access | Times Cited: 25
Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)2AReceptor (5-HT2AR), 5-HT2CR, 5-HT1AR, and Serotonin Transporter
Laura B. Kozell, Amy J. Eshleman, Tracy L. Swanson, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 385, Iss. 1, pp. 62-75
Open Access | Times Cited: 24
Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study
Jessica Barbut Siva, Tommaso Barba, Hannes Kettner, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 2, pp. 145-155
Open Access | Times Cited: 11
Flexible scaffold-based cheminformatics approach for polypharmacological drug design
Zhangcheng Chen, Jing Yu, Huan Wang, et al.
Cell (2024) Vol. 187, Iss. 9, pp. 2194-2208.e22
Closed Access | Times Cited: 11
Is it now time to prepare psychiatry for a psychedelic future?
David Nutt, Ilana Crome, Allan H. Young
The British Journal of Psychiatry (2024) Vol. 225, Iss. 2, pp. 308-310
Open Access | Times Cited: 10
Psychedelics and sexual functioning: a mixed-methods study
Tommaso Barba, Hannes Kettner, Caterina Radu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain Management
Natalie Strand, Madeline Whitney, Brooks Johnson, et al.
Current Pain and Headache Reports (2025) Vol. 29, Iss. 1
Closed Access | Times Cited: 1
From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS)
Richard J. Zeifman, Meg J. Spriggs, Hannes Kettner, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Positive effects of psychedelics on depression and wellbeing scores in individuals reporting an eating disorder
Meg J. Spriggs, Hannes Kettner, Robin Carhart‐Harris
Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity (2020) Vol. 26, Iss. 4, pp. 1265-1270
Closed Access | Times Cited: 69
Psychedelics as an emerging novel intervention in the treatment of substance use disorder: a review
Alec James Divito, Robert F Leger
Molecular Biology Reports (2020) Vol. 47, Iss. 12, pp. 9791-9799
Closed Access | Times Cited: 56
The emerging role of psilocybin and MDMA in the treatment of mental illness
Hartej Gill, Barjot Gill, David Chen‐Li, et al.
Expert Review of Neurotherapeutics (2020) Vol. 20, Iss. 12, pp. 1263-1273
Closed Access | Times Cited: 54
From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders
Urszula Kozłowska, Charles D. Nichols, Kalina Wiatr, et al.
Journal of Neurochemistry (2021) Vol. 162, Iss. 1, pp. 89-108
Open Access | Times Cited: 54
A narrative synthesis of research with 5-MeO-DMT
Anna O. Ermakova, Fiona Dunbar, James Rucker, et al.
Journal of Psychopharmacology (2021) Vol. 36, Iss. 3, pp. 273-294
Open Access | Times Cited: 51
Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective
John R. Kelly, Claire M. Gillan, Jack Prenderville, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 51
Novel antidepressant drugs: Beyond monoamine targets
Xénia Gonda, Péter Döme, Joanna C. Neill, et al.
CNS Spectrums (2021) Vol. 28, Iss. 1, pp. 6-15
Closed Access | Times Cited: 49
On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review
Richard J. Zeifman, Nikhita Singhal, Leah Breslow, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 2, pp. 436-451
Open Access | Times Cited: 47
Psychedelic perceptions: mental health service user attitudes to psilocybin therapy
Kate Corrigan, Maeve Haran, Conor McCandliss, et al.
Irish Journal of Medical Science (1971 -) (2021) Vol. 191, Iss. 3, pp. 1385-1397
Open Access | Times Cited: 47
Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample
Keri Mans, Hannes Kettner, David Erritzøe, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 45

Scroll to top